Dr. Boles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9400 Campus Point Drive
UCSD Komen Outpatient Pavilion, 3rd Floor
La Jolla, CA 92037Phone+1 858-249-3249Fax+1 858-249-3250
Summary
- Sarah (Montross) Boles, MD, is an Oncology specialist based in La Jolla, California. She focuses on treating breast cancer and sarcoma, with particular experience in desmoid tumor, breast cancer, desmoid fibromatosis, sarcomas, and giant cell tumors of the bone. She completed her Residency in Internal Medicine at UCLA David Geffen School of Medicine/UCLA Medical Center and Fellowship in Hematology and Medical Oncology at the University of California (San Diego) Medical Center. She has numerous publications in reputable journals, notably related to cancer research. Dr. Boles also received CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, Epic Systems Corporation in 2011-2013.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2001 - 2004
- Johns Hopkins University School of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2003 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- 6 citationsDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-12-01 - 1 citationsNear-Complete Pathological Response to Abemaciclib in the Treatment of Well-Differentiated/Dedifferentiated Liposarcoma: A Case Report.Nicholas C Neel, Jason K Sicklick, Somaye Zare, Sarah G Boles
JCO Precision Oncology. 2023-06-01 - 1 citationsPregnancy-associated large pelvic desmoid tumor: A case report of fetal-protective strategies and fertility preservation.Brennan Marsh-Armstrong, Jula Veerapong, Michael Taddonio, Sarah Boles, Jason K Sicklick
Gynecologic Oncology Reports. 2022-02-01
Press Mentions
- Malignant Bowel ObstructionFebruary 10th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: